A study to assess the equivalence in efficacy of anesthesia using topical Proxymetacaine 0.5% drops versus sub-conjunctival Lignocaine 2% (without adrenaline) for subsequent Intravitreal Injections of Ranibizumab (Lucentis): A Randomized Clinical Trial. - IVT Lucentis Anaesthetic Trial
- Conditions
- Wet Age-related Macular Degeneration
- Registration Number
- EUCTR2010-022644-21-GB
- Lead Sponsor
- Plymouth Hospitals NHS Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 150
Participant is willing and able to give informed consent for participation in the study.
Male or Female, aged 50 years or above.
Patients receiving subsequent doses of Intra Vitreal Lucentis Injection with a primary diagnosis of wet age related macular degeneration
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Patients not consenting to be included in the study.
Patients on pain medication.
Patients undergoing other Intra Vitreal procedure.
Patients undergoing Intra Vitreal injection of Ranibizumab for the first time.
Patients allergic to any components of the drug used in the study
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method